while i love you’re enthusiasm, its not about believing in anything. In my opinion the available information from announcements, the clinical data available indicates this treatment has a positive effect. How much? I think a lot more data is required.
The market potential is significant / sales potential. And as mentioned in the announcement the board think approval will be completed in a few months Dec/Jan. True not dissimilar announcements have been made in the past, but in this case it has come after a review where the board had to address those issues raised.
That’s not to say new issues couldn’t be raised regarding the recent presentation and submission, of course it could. However i would think the role out of a new medical device and the controls / governance model would be a fairly standard model that the medical industry would adhere to.
So a good opportunity to either invest in a SP gain or the company. I think in 1 year the SP could hit between 0.6 to 1.1, 2 years 1.2 to 2.0. In 3 years 2.0 to 3.0. A lot of $$$ to be made along the way for investors. A LOT more if you accumulate at these levels. All in my opinion and as always DYOR.
OSL Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)